Schwab Charles Investment Management Inc. Purchases 83,717 Shares of Danaher Corporation (NYSE:DHR)
Schwab Charles Investment Management Inc. boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 4.7% during the first quarter, Holdings Channel reports. The institutional investor owned 1,877,249 shares of the conglomerate’s stock after buying an additional 83,717 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Danaher Corporation were worth $160,562,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in DHR. Peddock Capital Advisors LLC increased its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter valued at approximately $157,000. Motco increased its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares in the last quarter. Baystate Wealth Management LLC increased its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares in the last quarter. Finally, Cedar Wealth Management LLC increased its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock valued at $196,000 after buying an additional 115 shares in the last quarter. Hedge funds and other institutional investors own 76.56% of the company’s stock.
Danaher Corporation (NYSE:DHR) traded up 0.67% on Friday, reaching $79.82. The company’s stock had a trading volume of 2,433,944 shares. The company’s 50 day moving average price is $82.89 and its 200-day moving average price is $84.21. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The stock has a market cap of $55.45 billion, a PE ratio of 25.48 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same quarter in the previous year, the company posted $0.90 earnings per share. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. On average, equities analysts expect that Danaher Corporation will post $3.95 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Schwab Charles Investment Management Inc. Purchases 83,717 Shares of Danaher Corporation (NYSE:DHR)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/schwab-charles-investment-management-inc-purchases-83717-shares-of-danaher-corporation-nysedhr/1479080.html.
DHR has been the subject of several recent research reports. Deutsche Bank AG restated a “buy” rating and set a $97.00 price objective on shares of Danaher Corporation in a report on Wednesday, June 21st. Credit Suisse Group restated a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a report on Wednesday, May 24th. BTIG Research restated a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. Finally, Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a report on Friday, July 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation presently has a consensus rating of “Buy” and an average price target of $91.76.
In related news, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock valued at $3,206,426 in the last ninety days. 12.20% of the stock is currently owned by corporate insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.